Authors Affiliation(s)
- Unit of Excellence in Cancer Genetics, Department of Genetics, School of Biological Sciences, Centre for Excellence in Genomic Sciences, Madurai Kamaraj University, Madurai 625021, INDIA
Can J Biotech, Volume 1, Special Issue, Page 69, DOI: https://doi.org/10.24870/cjb.2017-a56
*Corresponding author: kumar@oncocellomics.org
Abstract
HIF1α is a transcription factor activated under hypoxic condition in many cancer types and has been implicated in cancer cell proliferation, invasion and energy metabolism. Towards understanding the role of HIF1α mediated transcription in gastric cancer, the HIF1α gene signatures established to date were analyzed for their expression across the mRNA profiles of gastric tumors. HIF1α regulated genes were identified to involve and associated with the signaling pathways and processes such as integrin signaling, Wnt, P53, EGF, FGF, VEGFA, PI3K, TGFβ and NFkB signaling pathways. The HIF1a genes were identified to play a significant role in energy metabolism including glycolysis, drug resistance due to epithelial to mesenchymal transition and cancer cell survival. In gastric tumors, the HIF1α regulated genes were observed to express in diffuse, poorly differentiated and stage-3 tumors. The analyses reveal i) activation of HIF1 in a sub-set of gastric tumors, ii) the pathways associated with the HIF1 activation in gastric tumors, and iii) genes involved in HIF1α mediated transcription in gastric cancer. We are further investigating the drugs that would best suit for this sub-set of tumors with activated HIF1α.
References
- Masoud, G.N. and Li, W. (2015) HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharmaceutica Sinica B5: 378-389. Crossref
- Marín-Hernández, A., Gallardo-Pérez, J.C., Ralph, S.J., Rodríguez-Enríquez, S. and Moreno-Sánchez, R. (2009) HIF-1α modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9: 1084-1101. Crossref
- Ziello, J.E., Jovin, I.S. and Huang, Y. (2007) Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med80: 51-60.